Literature DB >> 28958480

Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.

Kyu-Hyun Han1, Ae-Kyeong Kim1, Min-Hee Kim1, Do-Hyung Kim1, Ha-Nl Go1, Donglim Kang1, Jong Wook Chang2, Soon Won Choi3, Kyung-Sun Kang3, Dong-Ik Kim4.   

Abstract

The aim of the present study was to investigate protein profiles of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) cultured in normoxic (21% O2) and hypoxic (1% O2) conditions, and evaluate oxygenation effects on angiogenesis in an ischemic hindlimb mouse model using a modified ischemic scoring system. Hypoxic conditions did not change the expression of phenotypic markers and increased adipogenesis and chondrogenesis. Epidermal growth factor (EGF), transforming growth factor alpha (TGF-α), TGF-β RII, and vascular endothelial growth factor (VEGF) were upregulated in the conditioned medium of hypoxic hUCB-MSCs, which are commonly related to angiogenesis and proliferation of biological processes by Gene Ontology. In the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, significant enrichment of the phosphorylation of abelson murine leukemia viral oncogene homolog 1 (ABL1) (Phospho-Tyr204) and B-cell lymphoma-extra large (BCL-XL) (Phospho-Thr47) as anti-apoptotic pathways was observed in hypoxic hUCB-MSCs. Furthermore, hypoxic conditions induced proliferation and migration, and reduced apoptosis of hUCB-MSCs in vitro. Based on the results of protein antibody array, we evaluated the angiogenic effects of injecting normoxic or hypoxic hUCB-MSCs (1×106) into the ischemic hindlimb muscles of mice. Ischemic scores and capillary generation were significantly greater in the hypoxic hUCB-MSC injection group than in the normoxic hUCB-MSC group. Our findings demonstrate that culturing hUCB-MSCs in hypoxic conditions not only significantly enriches phosphorylation in the anti-apoptosis pathway and enhances the secretion of several angiogenic proteins from cells, but also alleviates ischemic injury of hindlimb of mice.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Hypoxia; Ischemia; Mesenchymal stem cells

Mesh:

Year:  2017        PMID: 28958480     DOI: 10.1016/j.tice.2017.09.006

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  5 in total

1.  Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells.

Authors:  Luis A Rodriguez; Arezoo Mohammadipoor; Lucero Alvarado; Robin M Kamucheka; Amber M Asher; Leopoldo C Cancio; Ben Antebi
Journal:  Cells       Date:  2019-05-15       Impact factor: 6.600

2.  Enhanced Anti-Cancer Effects of Conditioned Medium from Hypoxic Human Umbilical Cord-Derived Mesenchymal Stem Cells.

Authors:  Kyu-Hyun Han; Ae-Kyeong Kim; Gun-Jae Jeong; Hye Ran Jeon; Suk Ho Bhang; Dong-Ik Kim
Journal:  Int J Stem Cells       Date:  2019-07-31       Impact factor: 2.500

Review 3.  Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells.

Authors:  Soyoun Um; Jueun Ha; Soo Jin Choi; Wonil Oh; Hye Jin Jin
Journal:  World J Stem Cells       Date:  2020-12-26       Impact factor: 5.326

4.  Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells.

Authors:  Ben Antebi; Luis A Rodriguez; Kerfoot P Walker; Amber M Asher; Robin M Kamucheka; Lucero Alvarado; Arezoo Mohammadipoor; Leopoldo C Cancio
Journal:  Stem Cell Res Ther       Date:  2018-10-11       Impact factor: 6.832

5.  Enhanced angiogenic activity of dimethyloxalylglycine-treated canine adipose tissue-derived mesenchymal stem cells.

Authors:  Sang-Min Kim; Qiang Li; Ju-Hyun An; Hyung-Kyu Chae; Ji-In Yang; Min-Ok Ryu; Aryung Nam; Woo-Jin Song; Hwa-Young Youn
Journal:  J Vet Med Sci       Date:  2019-10-02       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.